Array Microscope Assay for Cancer Cell Mechanics

癌细胞力学的阵列显微镜分析

• 批准号: 8333396
• 负责人: RICHARD SUPERFINE
• 金额: $ 30.91万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-15 至 2014-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8333396
• 关键词: Address; Adhesions; Affect; Apoptotic; Artificial Heart; Ascites; Automobile Driving; Basic Science; Behavior; Biochemical Genetics; Biochemical Pathway; Biological Assay; Biological Markers; Biomechanics; Bone Morphogenetic Proteins; Breast; Cancer Model; Cancer cell line; Cancerous; Cell Line; Cell Mobility; Cell division; Cell membrane; Cell model; Cells; Cellular biology; Characteristics; Clinical; Cytoskeleton; Data Analyses; Development; Diagnosis; Diagnostic; Diffusion; Disease; Disseminated Malignant Neoplasm; Environment; Epithelial; Epithelial Cell Proliferation; Epithelial Cells; Extracellular Matrix; Genetic Determinism; Goals; Heterogeneity; Hour; Human; Image; Immigration; In Vitro; Integrins; Lateral; Ligands; MDA MB 231; Magnetism; Malignant Neoplasms; Malignant neoplasm of ovary; Mammary Gland Parenchyma; Measurement; Measures; Mechanics; Mediating; Membrane; Mesenchymal; Methodology; Microscope; Migration Assay; Modeling; Mus; Nanotechnology; Neoplasm Metastasis; Ovarian; Ovarian Tissue; Pathogenesis; Patients; Process; Property; Rheology; S-Phase Fraction; Signal Transduction; Signal Transduction Pathway; Specimen; Staging; System; Time; Tissues; Translations; Tumor Biology; Tumorigenicity; abstracting; bioimaging; cancer cell; cancer therapy; cell motility; data acquisition; epithelial to mesenchymal transition; high throughput screening; indexing; inhibin; insight; instrument; magnetic beads; malignant breast neoplasm; member; metastatic process; migration; neoplastic cell; neuronal cell body; prognostic; prototype; receptor; response; software development; tool; treatment effect; tumor; tumor progression

DESCRIPTION (provided by applicant): Array Microscope Assay for Cancer Cell Mechanics Abstract As cells become cancerous, characteristic changes take place in their behavior that affect cell division as well as the ability of the cell to migrate or metastasize. Metastatic behavior, including cell migration, motility and adhesion, is one of the most damaging hallmarks of cancer. Current assays of cell metastases involve the observation of the lateral mobility of cells in a "scratch" assay, or the translation of cells through porous membranes. These assays usually take several hours to days of cell tracking. Metastatic potential has recently been associated with protrusive ability and cell body mechanical properties. We propose to replace the migration assay with one that measures the cell stiffness and cell mechanical response. This involves performing a calibrated tug on the cell with the measurement of the probe displacement. This measurement takes only seconds. This would allow the replacement of a five to forty eight hour assay with a one minute assay. More important than the simple benefit of a faster measurement on a single specimen, we propose an assay system that will allow high throughput methodologies to be applied to elucidating the time course of the biochemical pathways at the heart of the mechanical, and hence, metastatic propensity. We currently have a prototype multiwell assay system demonstrated on cancer cell mechanics. Our next steps are to move from a 16 well prototype to a 96 well assay, and to validate our system on cell lines and on ex-vivo tumor cells. Our development of high throughput force assays will be applied to relate tumorigenicity to the regulated expression of TGF-2 superfamily receptors and subsequent TGF-2 superfamily signaling. TGF-2 and the related TGF-2 superfamily ligands, the bone morphogenetic proteins (BMPs) and inhibin, are potent regulators of normal epithelial cell proliferation, differentiation, survival and migration, with frequent disruption in these homeostatic mechanisms resulting in human cancers and driving human cancer progression, including the metastatic process. We will assess dynamic changes in biomechanical properties during epithelial- mesenchymal transition (EMT), and investigate the migratory, invasive and metastatic potential of these cell models both in vitro (cell lines) and ex vivo and correlate these results with the biomechanical measurements. These measurements will validate our high throughput force system for a wide variety of cancer cell biology studies, enabling the elucidation of the biochemical and genetic determinants of metastatic behavior.

描述（由申请人提供）：随着细胞的癌细胞癌，阵列显微镜测定摘要，其行为发生了特征变化，这些变化会影响细胞分裂以及细胞迁移或转移的能力。转移行为，包括细胞迁移，运动和粘附，是癌症最具破坏性的标志之一。细胞转移的当前测定涉及在“刮擦”测定中观察细胞的横向迁移率，或通过多孔膜的细胞翻译。这些测定通常需要几个小时到几天的细胞跟踪。转移电位最近与突出能力和细胞体机械性能有关。我们建议用测量细胞刚度和细胞机械响应的迁移测定法。这涉及通过测量探针位移对细胞上进行校准的拖船。此测量仅需几秒钟。这将使用一分钟的测定法更换五到四十八小时的测定法。比在单个标本上更快测量的简单益处更重要，我们提出了一个测定系统，该系统将允许高通量方法用于阐明机械核心的生化途径的时间过程，因此，转移性倾向。目前，我们在癌细胞力学上展示了一个原型多井测定系统。我们的下一步是从16井原型转变为96井分析，并在细胞系和离体肿瘤细胞上验证我们的系统。我们对高吞吐力测定法的发展将应用于将肿瘤性与TGF-2超家族受体的调节表达和随后的TGF-2超家族信号传导相关联。 TGF-2和相关的TGF-2超家族配体，骨形态发生蛋白（BMP）和抑制素是正常上皮细胞增殖，分化，生存和迁移的有效调节剂，在这些稳态机制中经常破坏人类的稳态机制，并驾驶人类的稳态机制人类癌症的进展，包括转移过程。我们将评估上皮间充质转变（EMT）期间生物力学特性的动态变化，并研究这些细胞模型的迁移，侵入性和转移性潜力，无论是在体外（细胞系）和EX VIVO，并将这些结果与生物力学测量结果相关。这些测量结果将验证我们的高吞吐力系统进行多种癌细胞生物学研究，从而阐明转移性行为的生化和遗传决定因素。